pI: 4.5948 |
Length (AA): 608 |
MW (Da): 65494 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 161 | 1amu (A) | 33 | 190 | 15.00 | 0 | 0.68 | 0.476258 | -0.39 |
4 | 590 | 5msd (A) | 56 | 636 | 24.00 | 0 | 1 | 1.07626 | 0.71 |
11 | 605 | 5u29 (A) | 106 | 677 | 20.00 | 0 | 1 | 0.972418 | 0.78 |
15 | 238 | 5d6j (A) | 26 | 249 | 28.00 | 0.000000055 | 1 | 0.493221 | 0.07 |
361 | 467 | 6abh (D) | 333 | 450 | 38.00 | 0.000000008 | 0.75 | 0.368787 | 1.14 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_150506)
Species | Accession | Gene Product |
---|---|---|
Babesia bovis | BBOV_III010400 | long-chain acyl-CoA synthetase, putative |
Mycobacterium tuberculosis | Rv1550 | Probable fatty-acid-CoA ligase FadD11 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) |
Mycobacterium ulcerans | MUL_1546 | fatty-acid-CoA ligase FadD11 |
Plasmodium berghei | PBANKA_1453300 | acyl-CoA synthetase, putative |
Plasmodium falciparum | PF3D7_1238800 | acyl-CoA synthetase |
Plasmodium knowlesi | PKNH_1458600 | acyl-CoA synthetase, putative |
Plasmodium vivax | PVX_100890 | long-chain-fatty-acid--CoA ligase, putative |
Plasmodium yoelii | PY00791 | AMP-binding enzyme, putative |
Theileria parva | TP02_0107 | long-chain fatty acid CoA ligase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1578 | Mycobacterium tuberculosis | non-essential | nmpdr |
PBANKA_1453300 | Plasmodium berghei | Slow | plasmo |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Mycobacterium tuberculosis | Bifunctional enzyme MbtA: salicyl-AMP ligase (SAL-AMP ligase) + salicyl-S-ArCP synthetase | 565 aa | 22.6% | 477 aa | Compounds | References |
Photuris pennsylvanica | Luciferase | 552 aa | 25.2% | 492 aa | Compounds | References |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD28 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 580 aa | 24.2% | 487 aa | Compounds | References |
Photinus pyralis | Luciferin 4-monooxygenase | 550 aa | 23.5% | 498 aa | Compounds | References |
Luciola lateralis | Luciferase | 548 aa | 22.6% | 474 aa | Compounds | References |
Photuris pennsylvanica | Luciferin 4-monooxygenase | 545 aa | 22.5% | 494 aa | Compounds | References |
Yersinia pestis | AMP-binding enzyme family protein | 525 aa | 23.9% | 486 aa | Compounds | References |